Literature DB >> 9331204

Radiation optic neuropathy after stereotactic radiosurgery.

C A Girkin1, C H Comey, L D Lunsford, M L Goodman, L B Kline.   

Abstract

PURPOSE: The purpose of the study is to report the occurrence of optic neuropathy after stereotactic radiosurgery for perichiasmal tumors.
METHODS: Records of four patients with visual deterioration after stereotactic radiosurgery were reviewed, including clinical findings, neuroimaging results, and treatment methods.
RESULTS: Optic neuropathy developed 7 to 30 months after gamma knife radiosurgery. All patients experienced an abrupt change in visual function. Clinical findings indicated anterior visual pathway involvement. Patterns of field loss included nerve fiber bundle and homonymous hemianopic defects. Gadolinium-enhanced magnetic resonance imaging (MRI) showed swelling and enhancement of the affected portion of the visual apparatus in three patients. Systemic corticosteroids were administered in all patients and one partially recovered. One patient also received hyperbaric oxygen without improvement.
CONCLUSIONS: Although rare, optic neuropathy may follow radiosurgery to lesions near the visual pathways. Careful dose planning guided by MRI with restriction of the maximal dose to the visual pathways to less than 8 Gy will likely reduce the incidence of this complication.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9331204     DOI: 10.1016/s0161-6420(97)30084-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  23 in total

Review 1.  Role of gamma knife radiosurgery in acromegaly.

Authors:  I M Jackson; G Noren
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

2.  Influence of eye size and beam entry angle on dose to non-targeted tissues of the eye during stereotactic x-ray radiosurgery of AMD.

Authors:  Justin L Cantley; Justin Hanlon; Erik Chell; Choonsik Lee; W Clay Smith; Wesley E Bolch
Journal:  Phys Med Biol       Date:  2013-09-12       Impact factor: 3.609

3.  Safety and efficacy of multisession gamma knife radiosurgery for residual or recurrent pituitary adenomas.

Authors:  Luigi Albano; Marco Losa; Francesco Nadin; Lina Raffaella Barzaghi; Veronica Parisi; Antonella Del Vecchio; Angelo Bolognesi; Pietro Mortini
Journal:  Endocrine       Date:  2019-02-23       Impact factor: 3.633

4.  Risk factors for radiation-induced optic neuropathy: a case-control study.

Authors:  Ian Ferguson; Julie Huecker; Jiayi Huang; Collin McClelland; Gregory Van Stavern
Journal:  Clin Exp Ophthalmol       Date:  2017-03-09       Impact factor: 4.207

5.  Optimal strategy of gamma knife radiosurgery for craniopharyngiomas.

Authors:  Yun-Sik Dho; Yong Hwy Kim; Jin Wook Kim; Chul-Kee Park; Hyun-Tai Chung; Seung-Ki Kim; Sun Ha Paek; Kyu-Chang Wang; Dong Gyu Kim
Journal:  J Neurooncol       Date:  2018-07-09       Impact factor: 4.130

Review 6.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

7.  Clinical outcomes of perioptic tumors treated with hypofractionated stereotactic radiotherapy using CyberKnife® stereotactic radiosurgery.

Authors:  Putipun Puataweepong; Mantana Dhanachai; Ake Hansasuta; Somjai Dangprasert; Chomporn Sitathanee; Rawee Ruangkanchanasetr; Pornpan Yongvithisatid
Journal:  J Neurooncol       Date:  2018-05-30       Impact factor: 4.130

8.  Complications after gamma knife radiosurgery for benign meningiomas.

Authors:  J H Chang; J W Chang; J Y Choi; Y G Park; S S Chung
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

9.  A prospective study of cavernous sinus surgery for meningiomas and resultant common ophthalmic complications (an American Ophthalmological Society thesis).

Authors:  Steven Newman
Journal:  Trans Am Ophthalmol Soc       Date:  2007

10.  Radiation-induced optic neuritis after pituitary adenoma radiosurgery in a patient with multiple sclerosis: case report.

Authors:  Thomas B Daniels; Bruce E Pollock; Robert C Miller; Claudia F Lucchinetti; Jacqueline A Leavitt; Paul D Brown
Journal:  J Neurooncol       Date:  2008-12-20       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.